Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Claire Brulle-Wohlhueter"'
Autor:
Linong Ji, Roshan Shah, Patricia Guyot, Lawrence Blonde, Claire Brulle-Wohlhueter, Toby Sayre, Erin Murray, Philip Home, Alka Shaunik, Sanjay Kalra
Publikováno v:
Diabetes, Obesity and Metabolism. 22:2179-2188
AIM To assess the efficacy and safety of iGlarLixi, a fixed-ratio combination of insulin glargine 100 U/mL and lixisenatide, relative to premix insulin and other insulin options through network meta-analysis. METHODS A systematic literature search id
Autor:
Cécile Baradez, Jan Liska, Claire Brulle-Wohlhueter, Divya Pushkarna, Mike Baxter, John Piette
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(4)
With the advent of the COVID-19 pandemic, health systems increasingly look to digital health solutions to provide support for self-management to people with type 2 diabetes (T2D). This review aimed to assess brief digital behavior change solutions (i
Autor:
Riccardo C. Bonadonna, Claire Brulle-Wohlhueter, Pratik Choudhary, Jean-François Yale, Timothy S. Bailey, Emmanuelle Boëlle-Le Corfec
Publikováno v:
Diabetes, Obesity & Metabolism
Basal insulin therapy often involves a compromise between achievement of glycaemic targets and avoidance of hypoglycaemia, dependent on how intensively insulin is titrated. In the Phase 3a EDITION 1, 2 and 3 studies, insulin glargine 300 U/mL (Gla‐
Autor:
null Philip Home, null Lawrence Blonde, null Sanjay Kalra, null Linong Ji, null Patricia Guyot, null Claire Brulle‐Wohlhueter, null Erin Murray, null Roshan Shah, null Toby Sayre, null Alka Shaunik
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33cabefd29107ea993f5cc625affda17
https://doi.org/10.1111/dom.14148/v3/response1
https://doi.org/10.1111/dom.14148/v3/response1
Autor:
Claire Brulle-Wohlhueter, Isabel Muehlen-Bartmer, Helen Baron, Monica Bertolini, Stewart B. Harris, Melanie Espinasse, Medha Munshi, Geremia B. Bolli, Robert Ritzel, Nianxian Zhang, Ronan Roussel, Hermes Florez
Publikováno v:
Diabetes Care
OBJECTIVE SENIOR compared the efficacy and safety of insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in older people (≥65 years old) with type 2 diabetes. RESEARCH DESIGN AND METHODS SENIOR was an open-label, two-arm, p
Autor:
Robert Ritzel, Hannele Yki-Järvinen, Andrea Giaccari, Ronan Roussel, Claire Brulle-Wohlhueter, Jiten Vora
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate the efficacy and safety of insulin glargine 300 U/mL (Gla-300) vs insulin glargine 100 U/mL (Gla-100) over 12 months in a patient-level meta-analysis, using data from the EDITION studies in people with type 2 diabetes (T2DM). Meth
Autor:
Riccardo C. Bonadonna, Jean-François Yale, Timothy S. Bailey, E Boëlle-Le Corfec, Claire Brulle-Wohlhueter, Pratik Choudhary
Publikováno v:
Diabetologie und Stoffwechsel. 12:S1-S84
Autor:
Melanie Espinasse, Claire Brulle-Wohlhueter, Geremia B. Bolli, Helen Baron, Isabel Muehlen-Bartmer, Stewart B. Harris, Monica Bertolini, Hermes Florez, Robert Ritzel, Nianxian Zhang, Ronan Roussel, Medha Munshi
Publikováno v:
Diabetes care. 42(8)
In the article cited above, the ClinicalTrials.gov registration number was incorrect in the …
Autor:
Lori Berard, Junlong Wu, Harald Pohlmeier, Irene Nowotny, David C. Klonoff, Raphael Dahmen, Claire Brulle-Wohlhueter
Publikováno v:
Journal of Diabetes Science and Technology. 11:263-269
Background:Insulin glargine 300 U/mL (Gla-300) contains the same active ingredient as glargine 100 U/mL (Gla-100), and provides the same number of units in one-third of the volume. The SoloSTAR®injector pen has been modified to ensure accurate admin
Autor:
Claire Brulle-Wohlhueter, Alan J. Sinclair, C. Trescoli, Geremia B. Bolli, Vanita R. Aroda, G. Bigot, Robert Ritzel, Bernard Charbonnel, Ana Merino-Trigo, Jean-François Yale, A. Cahn
Publikováno v:
Diabetesmetabolism. 46(2)
Aim Older people with type 2 diabetes (T2DM) are at an increased risk of hypoglycaemia and its consequences. However, efficacy and safety data for basal insulin therapy are limited in these individuals. This patient-level meta-analysis assessed the t